PG Course-PB (Korean)
Nov. 15 (Thu)
09:00-10:30
Recent advances and problems in the management of pancreatobiliary disease E1+2 (3F)
Chairperson(s) Sang-Heum Park (Cheonan), Sang-Woo Cha (Seoul)
09:00-09:20 Pancreatobiliary maljunction: diagnostic criteria and proper management Hyo Jung Kim
(Seoul)
09:20-09:40 Optimal management of intrahepatic duct stones Chang Hwan Park
(Gwangju)
09:40-10:00 Recent advances in the management of advanced pancreatic neuroendocrine tumor Chang Min Cho
(Daegu)
10:00-10:20 Endoscopic management of biliary complication after liver transplantation Jimin Han
(Daegu)
10:20-10:30 Q&As
PG Course-PB
Nov. 15 (Thu)
11:00-12:30
Recent Progresses and optimal management of pancreatobiliary diseases 103 (1F)
Chairperson(s) Yong-Tae Kim (Seoul), Jin Hong Kim (Suwon)
11:00-11:20 Acute severe pancreatitis; Initial management, indications, timing and therapeutic modalities for drainage D. Nageshwar Reddy
(Hyderabad)
11:20-11:40 Pancreatic cystic neoplasm; Differential diagnosis, management & surveillance Young Deok Cho
(Seoul)
11:40-12:00 Bile duct stones and complications; Indication, timing and role of EUS, ERCP and cholecystectomy Masayuki Kitano
(Wakayama)
12:00-12:20 Cholangiocarcinoma; Diagnosis, staging and pre-operative tissue acquisition and stenting Ichiro Yasuda
(Toyama)
12:20-12:30 Q&As
Symposium PB-01
Nov. 16 (Fri)
08:30-10:00
New insights in the biliary system 104 (1F)
Chairperson(s) D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing)
08:30-08:50 Optimal evaluation of premalignant biliary lesions Seon Mee Park
(Cheongju)
08:50-09:10 Optimal approach to the indeterminate bile duct stricture Hsiu-Po Wang
(Taipei)
09:10-09:30 Updates on difficult biliary stones management Chang-Il Kwon
(Seongnam)
09:30-09:50 Best Endoscopic drainage of biliary system Shutian Zhang
(Beijing)
09:50-10:00 Q&As
Free Paper (PB 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (PB 01) E3 (3F)
Chairperson(s) Young Woo Choi (Daejeon), Kyu Taek Lee (Seoul)
08:30-08:40 Comparison of therapeutic efficacy and safety between standard-dose FOLFIRINOX and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer: a retrospective study Huapyong Kang
(Seoul)
08:40-08:50 Korean experiences with liposomal irinotecan for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. Juyeon Oh
(Goyang)
08:50-09:00 Comparison of FOLFIRINOX and Gemcitabine with Nab-paclitaxel in Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer Registry (K-PAC) Jong-Chan Lee
(Seongnam)
09:00-09:10 Surveillance versus surgery for incidental, asymptomatic, small solid pseudopapillary neoplasm (SPN) of the pancreas Joune Seup Lee
(Seoul)
09:10-09:20 Efficacy of endobiliary radiofrequency ablation for malignant distal biliary obstruction: A propensity score matched multicenter study Eui Joo Kim
(Incheon)
Chairperson(s) Seokho Dong (Seoul), Don Haeng Lee (Incheon)
09:20-09:30 The importance of elevated serum viscosity in pancreaticobiliary cancer patients Hwang Seonyeong
(Seoul)
09:30-09:40 Prognostic impact of minimal Pelvic Fluid in pancreatic cancer stage III Young-Hwa Kim
(Incheon)
09:40-09:50 Chromogranin A as a prognostic marker in pancreatic adenocarcinoma Jung Hyun Jo
(Seoul)
09:50-10:00 complementary role of Serum DUPAN-2 for screening of Carbohydrate Antigen 19-9 in patients with pancreatico-biliary malignancy Jae Woo Kim
(Wonju)
Free Paper (PB 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (PB 02) E3 (3F)
Chairperson(s) Tae Nyeun Kim (Daegu), Young Deok Cho (Seoul)
10:30-10:40 Differences in clinical features and outcomes of hypertriglyceridemia induced acute pancreatitis from the prospective acute pancreatitis registry of 558 patients. So Jeong Kim
(Incheon)
10:40-10:50 Acute pancreatitis in pregnant women. Features of diagnosis and treatment tactics Nurmurod Ne'mat O'g'li Esanov
(Tashkent)
10:50-11:00 Risk factors and outcomes of deep vein thrombosis in patients with necrotizing pancreatitis Du-Jiang Yang
(Chengdu)
Chairperson(s) Hong Sik Lee (Seoul), Byung Moo Yoo (Suwon)
11:00-11:10 Comparison between groove pancreatitis and groove pancreatitis with extensive chronic pancreatitis Jae Hyuck Jun
(Daejeon)
11:10-11:20 Comparison of clinical outcomes between plastic stent and lumen-apposing metal stent for endoscopic ultrasound-guided drainage of peripancreatic fluid collections: A retrospective single centre experience Chang Min Cho
(Daegu)
11:20-11:30 Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: A prospective, randomized, placebo-controlled study Byung Sam Park
(Daegu)
Symposium PB-02
Nov. 16 (Fri)
14:00-15:30
Cutting edge of pancreatic diseases 104 (1F)
Chairperson(s) Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei)
14:00-14:20 Updates on the management of severe acute pancreatitis Chengwei Tang
(Chengdu)
14:20-14:40 Pancreatic enzyme replacement therapy in chronic pancreatitis Hong Sik Lee
(Seoul)
14:40-15:00 Updates on Ig G4 related diseases Kazuichi Okazaki
(Hirakata)
15:00-15:20 Current status of pancreatic cystic neoplasm management Aiming Yang
(Beijing)
15:20-15:30 Q&As
Free Paper (PB 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (PB 03) E3 (3F)
Chairperson(s) Jaeseon Kim (Seoul), Seon Mee Park (Cheongju)
14:00-14:10 Acalculous cholecystitis in burn intensive care unit patients: Incidence and predisposing factors Hoongoo Lee
(Hwaseong)
14:10-14:20 Clinical characteristics of colonic adenoma according to characteristics of gallstones Jaehyun Tae
(Seoul)
14:20-14:30 Chronological changes of epidemiologic characteristics of gallstone over last 20years in Korean single large volume center Jiyong Zhao
(Seoul)
14:30-14:40 Incidence and risk factors for gallstone formation after surgical and endoscopic therapy Soyeong Kim
(Daegu)
Chairperson(s) Jin Lee (Hwasung), Jong Hyeok Kim (Anyang)
14:40-14:50 Incidence of cholelithiasis in patients with inflammatory bowel disease Sooyeong Kwak
(Daegu)
14:50-15:00 Biliary tuberculosis impersonating as cholangiocarcinoma: Single- center experiences Jae Hyuck Jun
(Daejeon)
15:00-15:10 Outcomes of endoscopic papillary large balloon dilation for bile duct stones: Before and after international consensus guideline Dae Jung Kim
(Suwon)
Symposium PB-03
Nov. 16 (Fri)
16:00-17:30
Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing? 203 (2F)
Chairperson(s) Ho Soon Choi (Seoul), Ji Kon Ryu (Seoul), Dong Sup Yoon (Seoul)
16:00-16:20 Pathogenesis and molecular characterization: from genetics to signaling pathways Young Nyun Park
(Seoul)
16:20-16:40 Pathologic classification: new concepts Kyoungbun Lee
(Seoul)
16:40-17:00 Endoscopic management: from ERCP to EUS Masayuki Kitano
(Wakayama)
17:00-17:20 Selection of patients for curative resection and role of surgery: from resection to transplantation Masayuki Ohtsuka
(Chiba)
17:20-17:30 Dong Hee Koh
(Hwaseong)
Free Paper (PB 4) (Korean)
Nov. 16 (Fri)
16:00-17:30
KDDW Free Paper (PB 04) E3 (3F)
Chairperson(s) Seong Woo Nam (Seoul), Young Koog Cheon (Seoul)
16:00-16:10 Antitumor effects of flavokawain B on cholangiocarcinoma Young Hoon Choi
(Seoul)
16:10-16:20 Carbohydrate antigen 19-9 as a prognostic marker of intrahepatic cholangiocarcinoma after surgical resection Gunn Huh
(Seoul)
16:20-16:30 Clinical relevance of BilIN in surgical margin of perihilar cholangiocarcinoma Soong Goo Jung
(Seoul)
Chairperson(s) Young Soo Moon (Busan), Se-Joon Lee (Yongin)
16:30-16:40 Efficacy and safety of simultaneous side-by-side bilateral placement of braided-type metal stents using 6F-introducer for unresectable malignant hilar bile duct obstruction: A retrospective feasibility study Doo Hyun Ko
(Inchon)
16:40-16:50 Comparison of preoperative CT scan, EUS Findings, and Histopathologic Findings of Gallbladder Polyps Larger than 1 cm in Size Jae Kook Yang
(Cheonan)
16:50-17:00 Long-term outcomes of endoscopic papillectomy after an insulated plastic pancreatic stent placement Sun Ung Youn
(Suwon)
Symposium PB-04
Nov. 17 (Sat)
08:30-10:00
Gallbladder disease: unsolved problems revisited 203 (2F)
Chairperson(s) Jong Kyun Lee (Seoul), Joo Ha Hwang (Stanford)
08:30-08:50 What are the true risk factors and precursors to gallbladder cancer? Joo Ha Hwang
(Stanford)
08:50-09:10 Differential diagnosis between gallbladder cancer and benign gallbladder disease Mi-Suk Park
(Seoul)
09:10-09:30 Endoscopic gallbladder drainage compared with percutaneous drainage: advantages and limitations Seong-Hun Kim
(Jeonju)
09:30-09:50 Surgical strategies for acute cholecystitis in the era of minimal invasive approach: when and how? Keun Soo Ahn
(Daegu)
09:50-10:00 Q&As
Symposium PB-05
Nov. 18 (Sun)
13:30-15:00
Recent advances in malignant pancreatobiliary diseases 104 (1F)
Chairperson(s) Dadang Makmun (Jakarta), Myung-Hwan Kim (Seoul)
13:30-13:50 How to find out the early detection of pancreatobiliry cancer Khek Yu Ho
(Singapore)
13:50-14:10 Optimal endoscopic management of Borderline non-resectable pancreatic cancer Eun Taek Park
(Busan)
14:10-14:30 Optimal management of borderline resectable pancreatic cancer Hidenori Takahashi
(Osaka)
14:30-14:50 Current Status and Future Directions in Chemotherapy for pancreatiBiliary Tract Cancer Seung Woo Park
(Seoul)
14:50-15:00 Q&As